Target cancer therapy could be achieved by self-complexation and complexation between β-carboline–β-cyclodextrin and doxorubicin. Self-complex/complex was formed at neutral normal tissues. It converted to complex at acidic tumor tissue. Thus, doxorubicin could be targeted and carried to tumor cells. The survival of mice had been improved.